SEC Filing Details

Document Details

Filing Date
Jan 16, 2008
Document Date
Jan 16, 2008
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
3,4,5
Company
Celldex Therapeutics
Issuer
CELLDEX THERAPEUTICS, INC.
Filer
TSP Capital Management Group, LLC

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline